IL288426A - An effective method for preparing ppr protein and using it - Google Patents
An effective method for preparing ppr protein and using itInfo
- Publication number
- IL288426A IL288426A IL288426A IL28842621A IL288426A IL 288426 A IL288426 A IL 288426A IL 288426 A IL288426 A IL 288426A IL 28842621 A IL28842621 A IL 28842621A IL 288426 A IL288426 A IL 288426A
- Authority
- IL
- Israel
- Prior art keywords
- preparing
- same
- efficient method
- ppr protein
- ppr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/85—Fusion polypeptide containing an RNA binding domain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019100551 | 2019-05-29 | ||
| PCT/JP2020/021472 WO2020241876A1 (ja) | 2019-05-29 | 2020-05-29 | 効率的なpprタンパク質の作製方法及びその利用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL288426A true IL288426A (en) | 2022-01-01 |
Family
ID=73553200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL288426A IL288426A (en) | 2019-05-29 | 2021-11-25 | An effective method for preparing ppr protein and using it |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220289795A1 (https=) |
| EP (1) | EP3978513A4 (https=) |
| JP (3) | JP7491515B2 (https=) |
| KR (1) | KR20220023985A (https=) |
| CN (1) | CN114729017A (https=) |
| AU (2) | AU2020283177B2 (https=) |
| BR (1) | BR112021023878A2 (https=) |
| CA (1) | CA3142299A1 (https=) |
| IL (1) | IL288426A (https=) |
| SG (1) | SG11202113055UA (https=) |
| WO (1) | WO2020241876A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3977849A4 (en) * | 2019-05-29 | 2023-06-28 | Editforce, Inc. | Ppr protein with less aggregation and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002322469B2 (en) * | 2001-07-12 | 2008-05-22 | Dna Landmarks, Inc. | Nuclear fertility restorer genes and methods of use in plants |
| JP2013128413A (ja) * | 2010-03-11 | 2013-07-04 | Kyushu Univ | Pprモチーフを利用したrna結合性蛋白質の改変方法 |
| WO2013058404A1 (ja) | 2011-10-21 | 2013-04-25 | 国立大学法人九州大学 | Pprモチーフを利用したrna結合性蛋白質の設計方法及びその利用 |
| KR102893770B1 (ko) * | 2013-04-22 | 2025-11-28 | 고쿠리쓰다이가쿠호진 규슈다이가쿠 | 피피알 단백질을 이용하는 dna 결합성 단백질 및 그의 이용 |
| WO2017209122A1 (ja) | 2016-06-03 | 2017-12-07 | 国立大学法人九州大学 | 標的mRNAからのタンパク質発現量を向上させるための融合タンパク質 |
| JPWO2018030488A1 (ja) * | 2016-08-10 | 2019-06-13 | 富士フイルム和光純薬株式会社 | Pprモチーフを利用したdna結合性タンパク質およびその利用 |
| US12441770B2 (en) * | 2018-06-06 | 2025-10-14 | The University Of Western Australia | Proteins and their use for nucleotide binding |
-
2020
- 2020-05-29 CN CN202080039706.2A patent/CN114729017A/zh active Pending
- 2020-05-29 CA CA3142299A patent/CA3142299A1/en active Pending
- 2020-05-29 SG SG11202113055UA patent/SG11202113055UA/en unknown
- 2020-05-29 EP EP20815305.6A patent/EP3978513A4/en active Pending
- 2020-05-29 AU AU2020283177A patent/AU2020283177B2/en active Active
- 2020-05-29 US US17/614,231 patent/US20220289795A1/en active Pending
- 2020-05-29 WO PCT/JP2020/021472 patent/WO2020241876A1/ja not_active Ceased
- 2020-05-29 JP JP2021521907A patent/JP7491515B2/ja active Active
- 2020-05-29 KR KR1020217040377A patent/KR20220023985A/ko active Pending
- 2020-05-29 BR BR112021023878A patent/BR112021023878A2/pt unknown
-
2021
- 2021-11-25 IL IL288426A patent/IL288426A/en unknown
-
2023
- 2023-08-02 JP JP2023126196A patent/JP7683865B2/ja active Active
-
2025
- 2025-05-02 JP JP2025076735A patent/JP2025107351A/ja active Pending
- 2025-06-30 AU AU2025204992A patent/AU2025204992A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025107351A (ja) | 2025-07-17 |
| AU2020283177A1 (en) | 2022-01-06 |
| JP7683865B2 (ja) | 2025-05-27 |
| JP7491515B2 (ja) | 2024-05-28 |
| JPWO2020241876A1 (https=) | 2020-12-03 |
| KR20220023985A (ko) | 2022-03-03 |
| WO2020241876A1 (ja) | 2020-12-03 |
| NZ783345A (en) | 2025-06-27 |
| AU2025204992A1 (en) | 2025-07-24 |
| SG11202113055UA (en) | 2021-12-30 |
| EP3978513A1 (en) | 2022-04-06 |
| US20220289795A1 (en) | 2022-09-15 |
| EP3978513A4 (en) | 2023-06-28 |
| CN114729017A (zh) | 2022-07-08 |
| AU2020283177B2 (en) | 2025-05-08 |
| BR112021023878A2 (pt) | 2022-01-25 |
| CA3142299A1 (en) | 2020-12-03 |
| JP2023145672A (ja) | 2023-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288373A (en) | flt3l-fc fusion proteins and methods of use | |
| ZA202001447B (en) | M-diamide compound and preparation method therefor and use thereof | |
| IL277194A (en) | Means and methods for glycoprofiling of protein | |
| SG11202012004SA (en) | Rna-targeting fusion protein compositions and methods for use | |
| ZA201903357B (en) | Novel polypeptide and method of producing imp using the same | |
| SG11202108734VA (en) | Anti-trem2 antibodies and methods of use thereof | |
| IL278036A (en) | 1HPK inhibitors, method of preparation and administration | |
| SG11202108403UA (en) | Anti-clec2d antibodies and methods of use thereof | |
| IL287318A (en) | Materials and methods for the production of proteins | |
| IL289952A (en) | Anti-ms4a4a antibodies and methods of using them | |
| SG11202101227TA (en) | Novel crispr-associated protein and use thereof | |
| ZA202103259B (en) | Modified cas9 protein, and use thereof | |
| IL290741A (en) | Antibodies against cd-96 and methods of using them | |
| SG11202111462VA (en) | Asx-specific protein ligases and uses thereof | |
| IL291461A (en) | Anti-alpha-synuclein antibodies and methods of using them | |
| IL276053A (en) | Therapeutic Gard and methods of its use | |
| IL288886A (en) | Antibodies and methods of use | |
| IL279178A (en) | Weird Cas9 protein and its use | |
| SG11202108415YA (en) | Direct extended reach system and method | |
| IL276243A (en) | A system for characterizing tissues and a method related thereto | |
| IL291284A (en) | Systems and methods for expression of proteins | |
| IL285368A (en) | Protein-based hydrogel | |
| IL288426A (en) | An effective method for preparing ppr protein and using it | |
| ZA202210284B (en) | Anti-trem1 antibodies and related methods | |
| IL281090A (en) | Alternative processes for the preparation of tubolysins and their intermediates |